Furanyl-rhodanines are unattractive drug candidates for development as inhibitors of bacterial RNA polymerase.

MARINER, K R, TROWBRIDGE, R, AGARWAL, A K, MILLER, Keith, O'NEILL, A J, FISHWICK, C W and CHOPRA, I (2010). Furanyl-rhodanines are unattractive drug candidates for development as inhibitors of bacterial RNA polymerase. Antimicrobial Agents and Chemotherapy, 54 (10), 4506-4509.

Full text not available from this repository.
Official URL: http://aac.asm.org/content/54/10/4506
Link to published version:: https://doi.org/10.1128/AAC.00753-10
Related URLs:

    Abstract

    Previous studies suggest that furanyl-rhodanines might specifically inhibit bacterial RNA polymerase (RNAP). We further explored three compounds from this class. Although they inhibited RNAP, each compound also inhibited malate dehydrogenase and chymotrypsin. Using biosensors responsive to inhibition of macromolecular synthesis and membrane damaging assays, we concluded that in bacteria, one compound inhibited DNA synthesis and another caused membrane damage. The third rhodanine lacked antibacterial activity. We consider furanyl-rhodanines to be unattractive RNAP inhibitor drug candidates.

    Item Type: Article
    Research Institute, Centre or Group - Does NOT include content added after October 2018: Biomolecular Sciences Research Centre
    Identification Number: https://doi.org/10.1128/AAC.00753-10
    Page Range: 4506-4509
    Depositing User: Rebecca Jones
    Date Deposited: 02 Mar 2012 12:02
    Last Modified: 10 Oct 2018 13:18
    URI: http://shura.shu.ac.uk/id/eprint/4509

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics